Code | 1732E | ||||||||||
MA number | EU/1/21/1537/005 | ||||||||||
Product Form: | tbl flm 8x20 mg (blis.PVC/PCTFE/PVC/Al ) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Stemline Therapeutics B.V., Netherland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Container: | blister PVC/PCTFE/PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 26.03.2021 |
Validity: | 18.07.2027 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 03.11.2022 |